Detalhe da pesquisa
1.
Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: An observational study using propensity score matching.
Prostate
; 2024 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734992
2.
Effectiveness of intraoral stents in reducing oral adverse events during radiotherapy for maxillary or nasal cavity malignant tumors.
Support Care Cancer
; 32(3): 150, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38329552
3.
Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapy.
Prostate
; 83(7): 701-712, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879383
4.
Erectile dysfunction and sexual quality of life in patients who underwent low-dose-rate brachytherapy alone for prostate cancer.
Andrologia
; 54(1): e14288, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693547
5.
Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy.
Int J Urol
; 29(12): 1560-1568, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125928
6.
Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low-dose-rate brachytherapy for localized prostate cancer.
Int J Urol
; 29(2): 143-151, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34763369
7.
Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil.
Int J Urol
; 28(11): 1171-1176, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378247
8.
Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.
Jpn J Clin Oncol
; 50(1): 58-65, 2020 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665354
9.
Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low-dose-rate brachytherapy: A randomized controlled study.
Int J Urol
; 27(11): 1013-1017, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783280
10.
Biochemical control of the combination of cyclooxygenase-2 inhibitor and 125 I-brachytherapy for prostate cancer: Post hoc analysis of an open-label controlled randomized trial.
Int J Urol
; 27(9): 755-759, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588515
11.
Clinical Results and Hematologic Predictors of Linear Accelerator-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective Study.
World Neurosurg
; 183: e944-e952, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244685
12.
Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy.
Brachytherapy
; 21(5): 626-634, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644732
13.
Mirabegron Reduces Urinary Frequency and Improves Overactive Bladder Symptoms at 3 Months After 125I-brachytherapy for Prostate Cancer: An Open-Labeled, Randomized, Non-Placebo-Controlled Study.
Urology
; 161: 87-92, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973240
14.
Factors affecting urinary frequency after low-dose-rate brachytherapy for prostate cancer.
Low Urin Tract Symptoms
; 14(1): 4-9, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288506
15.
Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain Metastasis.
Curr Oncol
; 29(9): 6068-6076, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36135046
16.
Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain Metastasis.
Curr Oncol
; 28(6): 5255-5265, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940078
17.
Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for large brain metastasis unsuitable for surgical resection.
J Radiat Res
; 61(4): 546-553, 2020 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32548618
18.
A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study.
Contemp Clin Trials Commun
; 19: 100593, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32637724
19.
Linac-Based Fractionated Stereotactic Radiotherapy with a Micro-Multileaf Collimator for Brainstem Metastasis.
World Neurosurg
; 132: e680-e686, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442651
20.
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer.
Clin Transl Radiat Oncol
; 14: 51-58, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547097